MTRC Webinar: MedTech Market Access in 2026: Key Developments and What Comes Next

The European MedTech market access environment continued to evolve throughout 2026, with important developments in reimbursement, healthcare policy, HTA methodology, and regular and innovative access pathways for medical technologies. At the EU level, implementation of the Health Technology Assessment Regulation advanced materially, including the first recommendation on selecting medical devices and IVDs for Joint Clinical Assessment.  

MTRC invites MedTech professionals to an online seminar reviewing the most important market access developments of 2026 and considering what manufacturers should prepare for in 2027 and beyond. The seminar will translate reimbursement, HTA and policy developments into practical implications for country prioritization, clinical and economic evidence planning, reimbursement strategy, and European launch preparation. 

During the seminar, we will discuss: 

• Major reimbursement, HTA, payer, and healthcare policy developments during 2026;  
• The progress of EU Joint Clinical Assessments for medical devices and IVDs;  
• Important developments in national reimbursement and innovative payment pathways;  
• How changes may affect clinical development, evidence generation, launch sequencing, and time to access;  
• Which developments are likely to become more important during 2027;  
• Practical actions MedTech companies should consider in their market access plans.  

The seminar will be particularly relevant to professionals working in Market Access, Reimbursement, HTA, HEOR, Clinical Development, Medical Affairs, Regulatory Affairs, Commercial Strategy, Portfolio Management, and European launch planning. 

Speaker: Dr Oleg Borisenko, Founder and Director of MTRC 

Date and time: 17.00 CET, December 17, 2026 

Format: Online seminar. The seminar will not be recorded.  

Participation: Only representatives of the medical technology industry.  

You can register here.